SlideShare a Scribd company logo
CHEMISTRY OF
PROSTAGLANDINS,
LEUKOTRIENES AND
THROMBOXANES
Presenting by,
Mr Purushotham KN Sir
Asst.Professor
Department of
Pharm.Chemistry.
SACCP,B.G.Nagara
2021-2022
CONTENTS :-
Eicosanoids
1. Prostaglandins
 Introduction
 Classification
 Chemical structure
 Biosynthesis of Prostaglandin
 Regulation of Prostaglandin
 Mechanism of action
 Theraupeutic uses
2. Leukotrienes
 Introduction
 Biosynthesis of Leukotrienes
 Mechanism of action
 Function of Leukotrienes
3. Thromboxanes
 Introduction
 Biosynthesis of Thromboxanes
 Function of Thromboxanes
 Application
Eicosanoids
INTRODUCTION
Eicosanoids are oxidised derivatives of 20-carbon
polyunsaturated fatty acids (PUFAs) formed by the
cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome .
Eicosanoids are Classified as
1. Prostanoids
• Prostaglandins
• Prostacyclins
• Thromboxanes
2. Leukotrienes
• Leukotrienes A4
• Leukotrienes B4
• Leukotrienes C4
• LeukotrienesD4
• Leukotrienes E4
3. Lipoxins
• Lipoxins A4
• Lipoxins B4
All Eicosanoids contain 20 carbon atom
Eicosanoids are considred as Locally acting hormone with wide
range of biochemical Function
And also Arachidonic acid is Precursor of eicosanoids in human
beings.
Prostaglandins
Introduction
CH3
O
OH
1
2
3
4
5
6
7
8
9
10
11 12
13
14
15
16
17
18
19
20
Prostanoic acid
 The prostaglandins (PG) are a group
of physiologically active lipid compounds
called eicosanoids having diverse hormone-like effects in
animals. Prostaglandins have been found in almost every tissue in
humans and other animals. They are derived enzymatically from
the fatty acid that is arachidonic acid
 Prostaglandin are derivative from hypothetical 20 carbon fatty
acid which is called as prostanoic acid and hence the name is
prostanoid.
The prostanoid has a 5 carbon cyclopentane ring which is form by
carbon 8 to carbon 12 and it has 2 side chain 1 chain of 7 carbons
these lied above plane of ring and other chain has below the ring.
Each of the biological active prostaglandin it has a hydroxyl
group at carbon number 15.
Classification of Prostaglandins
 There is 9 classes of Prostaglandins that are
 Prostaglandin A, Prostaglandin B, Prostaglandin C, Prostaglandin
D, Prostaglandin E, Prostaglandin F, Prostaglandin G,
Prostaglandin H, Prostaglandin I
 Prostaglandin are classified into three series.
 1 series which consist 1 double bond from linoleic acid
Prostaglandin E1.
 2 series which consist 2 double bond from Arachidonic acid
Prostaglandin E2.
 3 series which consist 3 double bond from Eicosapentaenoic acid
Prostaglandin E3.
OH
CH3
O
O
H
O OH
Prostaglandin E2
 And double bond between carbon 13 and 14 various
substituent at the cyclopentane ring.
 And also these structure has keto group at carbon 9 and
hydroxyl group at carbon 11.
Chemical structures
OH
CH3
O
H
O OH
O
H
Prostaglandin F2
These is the structure of Prostaglandine F2.
It has hydroxyl group at carbon number 9 and 11.
As other biologically active prostaglandin it has hydroxyl
group at carbon number 15.
double bond between 13 and 14.
Chemical structure of prostacyclins
Prostacyclins contain additional ring formed by cyclization of
side chain by linkage of carbon 6 to carbon 9 through oxygen
atom on that why it is called as Prostacyclins.
O
O
H
O
OH
O
H
CH3
Thromboxane had derivatives of oxane ring and it is a six memebered
ring intrepted by oxygen atom. these is interupted by oxygen ring and
also they are synthesized from arachidonic acid.
And also it synthesize in human body and it has additional oxygen
atom joined with carbon 9 and 11.
Prostaglandin are derivative of prostanoic acid which is 20 carbon
fatty acid and they are most potent biologically substances.
It produced in almost tissue except erythrocytes.
Thromboxane
Prostaglandin are different from true hormone in human body
Prostaglandins are thought to be local hormone secrete by prostate
hormone.
And also prostaglandin were first isolated from prostate gland
secreation hence it named as prostaglandin.
Sweedish scientist Ulf van euler got nobel prize in 1970 for
discovery of prostaglandin.
Prostaglandin actually derived from fatty acid called as Arachidonic
acid which is 20 Carbon fatty acid.
Biosynthesis of Prostaglandin
 At cellular level where are the prostaglandins produced and also
prostaglandin are very unstable compound and there half life
around 30 seconds.
 Prostaglandin synthesis is take place from the membrane
phospholipids.
 From the memebrane phospholipid it is cleaved by phospholipid
A2 It release precurser for prostaglandin synthesis which is
arachidonic acid.
 From that arachidonic acid in sequential enzymatic step
prostaglandin would be produced.
 This crucial step whenever it is required synthesize phospholipid
A2 releases arachidonic acid from membrane phospholipid there
by prostaglandin synthesis takes place.
 Now key enzyme for prostaglandin synthesis pathway is
Prostaglandin H synthase.
 Prostaglandin H synthase has 2 kind of activity one
cyclooxygenase activity and peroxidase activity.
 Cyclooxygenase activity forms prostaglandin G2 from
arachidonic acid.
 And also peroxidase activity that reduces prostaglandin G2 to
prostaglandin H2.
Regulation of Prostaglandin production
 The prostaglandin the key raw material of prostaglandin
production is arachidonic acid derived from cell membrane.
 And it is triggered by a enzyme which is phospholipase A2.
 Now modulating phospholipase A2 activity the prostaglandin
production from arachidonic acid derived from cell membrane.
 And it is triggered by a enzyme which is phospholipase A2
activity the prostaglandin production can be regulated.
 It turns out epinephrine Thrombin, Angiotensin ll , Bradykinin,
vasopressin are positively regulate phospholiphase A2 and that
leads to production of prostaglandin.
 Steroid kind of inhibit prostaglandin A2 activity and there by
prevent production of prostaglandin.
 Prostaglandin H synthase its activity triggered by cathecolamines.
 Where as it inhibit by compound like methyl salysilate and similar
compound like aspirin and others.
Mechanism of Action
 Prostaglandin found to be working G protein couple receptor
signalling pathway.
 An often prostaglandin stimulation leads to increase in cyclic
Amp and protein kinase.
 A activation followed by several nuclear changes in terms of
chin expression.
 Several Prostaglandin has several effect on different level
example prostaglandin I2 leads to vascular dilation.
 Whereas thromboxanes which is secreated or prevently present in
thrombocyte they induce vasoconstriction.
 And also these two has opposite function.
 Now prostaglandin I2 which is known as prostacyclin prevent
platelet aggregation.
 Where as thromboxanes promote platelet aggregation.
 In which prostaglandin F2 are stimulates uterine muscle
contraction sometimes used to terminate pregnancy.
 Now Prostaglandin E and Prostaglandin F has opposing role in
terms of broncho constriction and broncho dilation.
 Prostaglandin F leads bronchial smooth muscle constriction
where PGE leads to dilation of the bronchials.
 Prostaglandin E2 and Prostaglandin D2 increase capillary
permeability enabling neutrophill and other imune cell to be
extravated from particular blood capillary near by the tissue and
it also implicate in terms of inflamation.
So that Prostaglandin E2 and prostaglandin D2 are involved in
inflammatory responses.
Now overall prostaglandin prevent are decrease gastric
secreation and increase intestinal mobility.
THERAUPEUTIC USES
Abortion : PGs have a place in midterm abortion, missed
abortion. Methotrexate alongwith misoprostol is also highly
successful for inducing abortion in the first few weeks of
pregnancy. Pretreatment with mifepristone improves the efficacy
of PGE2 as abortifacient.
Cervical priming : Applied Intravaginally or in the cervical
canal, low doses of PGE2 which do not affect uterine motility,
make the cervix soft and compliant.
Glaucoma : Topical PGF2a analogues like lanatoprost, bimatoprost
that are receptor agonists are the first choice drugs in wide angle
glaucoma.
Peptic ulcer : PGEI (misoprostol) is occasionally used for healing
peptic ulcer.
Avoid Platelet damage : PGI2 (Epoprostenol) can be used to
prevent platelet aggregation and damage during haemodialysis.
Leukotrienes
INTRODUCTION
 Leukotrienes is kind of similar leukocytes. It kind of
associated with Leukocytes.
 Trienes are tell us some features of chemical.
 There are 3 consecutive double bond.
 Now we understand leukotrienes as kind of chemical
molecules which might have chemical features 3
consecutive double bond found in leukocytes.
 So these leukotrienes are actually a family of eicosanoids
(arachidonic acid derivatives).
 Leukotrienes are inflammatory mediators just like other
arachidonic derivative such as prostaglandin.
 Leukotrienes are a family of eicosanoid inflammatory
mediators produced in leukocytes by the oxidation of arachidonic
acid (AA) and the essential fatty acid eicosapentaenoic acid (EPA)
by the enzyme arachidonate 5-lipoxygenase.
 Leukotrienes use lipid signaling to convey information to either the
cell producing them (autocrine signaling) or neighboring cells
(paracrine signaling) in order to regulate immune responses.
 The production of leukotrienes is usually accompanied by the
production of histamine and prostaglandins, which also act as
inflammatory mediators.
5-lip-oxygenase act on arachidonic acid to form 5-
hydroperoxyeicosatetraenoic acid .
Acts and associate with 5-lox activating protein.
The 5HPETE later converted into leukotriene A4 also it is unstable
and rapidly hydrolyse by the action of enzyme by leukotriene A4
hydrolase to form leukotriene B4 in neutrophils and monocytes.
The LTB4 is one of the most potent inflammation mediating lipids.
And LTA4 (Leukotriene A4) which forms leukotriene C4 which
incorporate with glutathion and with action of LTC4 synthase it
forms leukotrienes C4.
Biosynthesis of Leukotrienes
This forms in mast cells and eosinophills.
Later Leukotriene C4 release glutamate to forms leukotriene D4.
Later leukotriene D4 release glycine it forms leukotriene E4.
MECHANISM OF ACTION
 Which is usually accompanied with the production of
prostaglandins and histamines which are inflamattory
mediators from arachidonic acid there could be production of
leukotrienes and also in otherside which form prostaglandin
derivatives which also take part in inflammatory response.
 Leukotrienes receptors are class of G-Protein couple receptor
so generally work by elevation of cyclic Amp in the cell and
leads to several inflammatory cytokinin genes.
 But few leukotrienes receptor also nuclear receptor type.
 And these receptor generally found in easinophil, endothelial
cells, mast cells.
 In endothelial cells and also found in smooth muscles cells
important role in smooth muscle contraction and they form
physiological role incase of disease.
Function of Leukotrienes
Major role of leukotrienes (specially, leukotrienes D4) is to trigger
contraction in the smooth muscle lining the bronchioles.
Contraction of branchioles is triggered by leukotriene and these is
the key underline feature rhinitis or asthma like diseases.
Leukotrienes contribute to the pathophysiology of asthma,
especially in patients with aspirin. Exacerbated respiratory disease
whose symptoms are
Airflow obstruction, Increased secretion of mucus, Mucosal
accumulation, Broncho constriction, Infiltration of inflammatory
cells in the airway wall.
Excess of leukotriene leads to anaphylactic shock.
Excess of leukotriene leads to anaphylactic shock
And also leukotrienes inhibitors could be useful for patients with later
stages of alzheimer disease.
And also improve memory loss
And also Leukotrienes classified as
Leukotrienes A4
Leukotrienes B4
Leukotrienes C4
Leukotrienes D4
Leukotrienes E4
Leukotrienes designated as 4 because 4 double bond in their structures
are
Leukotrienes are involved in the inflammation and immediate
hypersensitivity reaction.
Leukotriene B4
 Increased chemotaxis of polymorphonuclear leukocytes.
 Chemotaxis are directed migration of cell in response to
chemical stimulus such as growth factor.
 Release of lysosomal enzymes, adesion of white blood cells.
Leukotriene C4 , Leukotriene D4, Leukotriene E4
• Involved in contraction of smooth muscle.
• They cause Bronchoconstriction, and Vasoconstriction.
• They also called as slow reacting substance of anaphylaxis.
• Anaphylaxis is seveir potentially life threatening allergic reaction.
• And this reaction occur within seconds or minutes of exposure to
allergens.
Thromboxanes
INTRODUCTION
 Thromboxane is named for its role in clot formation.
 Thromboxane is a member of the family of lipids known as
eicosanoids and also it is derived from arachidonic acid.
 Arachidonic acid get converted into thromboxane A2 and
thromboxane B2.
 Key enzyme help in these process is known as
thromboxane-A-synthase.
 Both thromboxanes are characterized as 6-membered ether
containing cyclic ring.
Biosynthesis of Thromboxanes
o Thromboxanes is synthesized in platelet.
o On the platelet membrane they would be phospholiphase and these
would generate arachidonic acid.
o The arachidonic acid converted initially prostaglandin H2 with the
help of cyclo oxygenase.
o Later prostaglandin H2 is converted into either prostacyclin with the
help of prostacyclin synthase or it can converted into thromboxane
A2 with the help of Thromboxane A synthase.
o These Thromboxane A Synthase enzyme exclusively present in the
platelet membrane. Platelet is the site of thromboxane production.
Thromboxane once generated can bind to thromboxane receptor
present in wide variety of cell for example blood vessel.
Thromboxane ultimately leads to G-protein mediating signalling
which elevates calcium level in cytoplasm.
Once calcium level elevated it helps in clot formation or
eventually in vasoconstriction.
Function of Thromboxanes
 One of the major function of the thromboxane is to perform
vasoconstriction.
 Thromboxane and prostacyclin has opposite role.
 Prostacyclin has vasodilatory role where as thromboxanes has
vasoconstriction role.
 And also vasoconstriction caused by thromboxanes play a role in
prinz metal ’s angina and blocked coronary artery.
 Any kind of cardiac inflammatory disease one of the leading role
could be played by thromboxanes.
 In immune diet if human body has sufficient omega 3 fatty acid
thromboxane A3 has generated instead of thromboxane A2.
 While thromboxane A2 is potent vasoconstrictor and thromboxane
A3 is less potent vasoconstrictor.
 Vasoconstriction mediated effect is less if diet contain omega 3
fatty acid
 In this synthesis of thromboxane by blocking cycloxygenase
specific substance such has aspirin can block production of
thromboxane.
 Other than thromboxane synthase inhibitor inhibit thromboxane
A-synthase.
APPLICATION OF THROMBOXANES
 Thromboxanes exert hormone-like Application.
 They interact with G-protein-linked receptors on the cell surface
to activate signal transduction pathways inside the cell.
 TXs modify inflammatory responses but are most well-known for
their role in platelet aggregation, vasoconstriction, and smooth
muscle proliferation – they are an essential part of the wound
repair mechanism.
 Thromboxane synthesis and thus platelet aggregation is inhibited
by non-steroidal anti-inflammatory drugs like aspirin.
References
 https://pubmed.ncbi.nlm.nih.gov/32808658/#:~:text=Eicosanoids%20
are%20oxidised%20derivatives%20of,usual%20substrate%20for%20
eicosanoid%20synthesis.
 Medical pharmacology by KD Tripathi, 8th edition Page no-197 to
208.
 Medicinal chemistry by Prof. Surendra Nath Pandeya Page no- 239 to
249.
 https://en.m.wikipedia.org/wiki/Thromboxane#:~:text=Thromboxane
%20is%20a%20vasoconstrictor%20and,from%20platelets%20is%20s
till%20unclear.
 https://en.m.wikipedia.org/wiki/Prostaglandin
 https://en.m.wikipedia.org/wiki/Leukotriene
 Medicinal chemistry by K.Ilango & P valentina Page no-968-999.
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx

More Related Content

What's hot

Validation & Diversity of drug targets
Validation & Diversity of drug targetsValidation & Diversity of drug targets
Validation & Diversity of drug targets
SnigdhaBharadwaaj
 
Peptidomimetics
PeptidomimeticsPeptidomimetics
Peptidomimetics
AkshayYadav176
 
Wiliknsons reagent
Wiliknsons reagentWiliknsons reagent
Wiliknsons reagent
Shikha Popali
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdf
ShivalingMP
 
Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2
Nirali Mistry
 
Cox inhibitor
Cox inhibitorCox inhibitor
Cox inhibitor
shinganaarti
 
peptidomimetics.pdf
peptidomimetics.pdfpeptidomimetics.pdf
Active constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapyActive constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapy
Akshay Kank
 
Enzyme inhibition for M.Pharm
Enzyme inhibition for M.PharmEnzyme inhibition for M.Pharm
Enzyme inhibition for M.Pharm
Shikha Popali
 
Rational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptxRational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptx
RashuRaju
 
Role of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agentRole of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agent
Karanvir Rajput
 
organic reaction
organic reactionorganic reaction
organic reaction
NiketBajare
 
Combating drug resistance
Combating drug resistanceCombating drug resistance
Combating drug resistance
Ashok Jangra
 
STEREOCHEMISTRY AND DRUG ACTION.pptx
STEREOCHEMISTRY AND DRUG ACTION.pptxSTEREOCHEMISTRY AND DRUG ACTION.pptx
STEREOCHEMISTRY AND DRUG ACTION.pptx
AchalYawalkar
 
Analog design medicinal chemistry
Analog design medicinal chemistryAnalog design medicinal chemistry
Analog design medicinal chemistry
Mohit umare
 
PEPTIDOMIMETICS [M.PHARM, BSC, MSC, B.PHARM]
PEPTIDOMIMETICS [M.PHARM, BSC, MSC, B.PHARM]PEPTIDOMIMETICS [M.PHARM, BSC, MSC, B.PHARM]
PEPTIDOMIMETICS [M.PHARM, BSC, MSC, B.PHARM]
Shikha Popali
 
Combating drug resistance in anticancer therapy
Combating drug resistance in anticancer therapy Combating drug resistance in anticancer therapy
Combating drug resistance in anticancer therapy
ManingcinaSephe
 
Advanced Organic Chemistry - I
Advanced Organic Chemistry - IAdvanced Organic Chemistry - I
Advanced Organic Chemistry - I
Ajay Kumar
 
3. stereochemistry of steroids
3. stereochemistry of steroids3. stereochemistry of steroids
3. stereochemistry of steroids
DR.Gopinathan Narasimhan
 
Knorr Pyrazole Synthesis (M. Pharm)
Knorr Pyrazole Synthesis (M. Pharm) Knorr Pyrazole Synthesis (M. Pharm)
Knorr Pyrazole Synthesis (M. Pharm)
MohdShafeeque4
 

What's hot (20)

Validation & Diversity of drug targets
Validation & Diversity of drug targetsValidation & Diversity of drug targets
Validation & Diversity of drug targets
 
Peptidomimetics
PeptidomimeticsPeptidomimetics
Peptidomimetics
 
Wiliknsons reagent
Wiliknsons reagentWiliknsons reagent
Wiliknsons reagent
 
ANALOG DESIGN.pdf
ANALOG DESIGN.pdfANALOG DESIGN.pdf
ANALOG DESIGN.pdf
 
Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2
 
Cox inhibitor
Cox inhibitorCox inhibitor
Cox inhibitor
 
peptidomimetics.pdf
peptidomimetics.pdfpeptidomimetics.pdf
peptidomimetics.pdf
 
Active constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapyActive constituent of drugs used in diabetic therapy
Active constituent of drugs used in diabetic therapy
 
Enzyme inhibition for M.Pharm
Enzyme inhibition for M.PharmEnzyme inhibition for M.Pharm
Enzyme inhibition for M.Pharm
 
Rational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptxRational design of non- covalently and covalently binding.pptx
Rational design of non- covalently and covalently binding.pptx
 
Role of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agentRole of chirality in stereoselective and specific theraputic agent
Role of chirality in stereoselective and specific theraputic agent
 
organic reaction
organic reactionorganic reaction
organic reaction
 
Combating drug resistance
Combating drug resistanceCombating drug resistance
Combating drug resistance
 
STEREOCHEMISTRY AND DRUG ACTION.pptx
STEREOCHEMISTRY AND DRUG ACTION.pptxSTEREOCHEMISTRY AND DRUG ACTION.pptx
STEREOCHEMISTRY AND DRUG ACTION.pptx
 
Analog design medicinal chemistry
Analog design medicinal chemistryAnalog design medicinal chemistry
Analog design medicinal chemistry
 
PEPTIDOMIMETICS [M.PHARM, BSC, MSC, B.PHARM]
PEPTIDOMIMETICS [M.PHARM, BSC, MSC, B.PHARM]PEPTIDOMIMETICS [M.PHARM, BSC, MSC, B.PHARM]
PEPTIDOMIMETICS [M.PHARM, BSC, MSC, B.PHARM]
 
Combating drug resistance in anticancer therapy
Combating drug resistance in anticancer therapy Combating drug resistance in anticancer therapy
Combating drug resistance in anticancer therapy
 
Advanced Organic Chemistry - I
Advanced Organic Chemistry - IAdvanced Organic Chemistry - I
Advanced Organic Chemistry - I
 
3. stereochemistry of steroids
3. stereochemistry of steroids3. stereochemistry of steroids
3. stereochemistry of steroids
 
Knorr Pyrazole Synthesis (M. Pharm)
Knorr Pyrazole Synthesis (M. Pharm) Knorr Pyrazole Synthesis (M. Pharm)
Knorr Pyrazole Synthesis (M. Pharm)
 

Similar to Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx

Eicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptxEicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptx
PharmTecM
 
Eicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical studentsEicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical students
dinesh kumar
 
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINSSYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
chandraprakash dwivedi
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
Dipesh Tamrakar
 
Postaglandines
PostaglandinesPostaglandines
Postaglandines
Joon Jyoti Sahariah
 
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptxEICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
Rajendra Dev Bhatt
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
Darpan Phagiwala
 
PROSTAGLANDINS
PROSTAGLANDINSPROSTAGLANDINS
PROSTAGLANDINS
YESANNA
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
Bhagya Siripalli
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
Monika Uma Shankar
 
Eocosanoids
EocosanoidsEocosanoids
Eocosanoids
dnyanesh amle
 
eicosanoids by doctor Mariam namusoke phd
eicosanoids by doctor Mariam namusoke phdeicosanoids by doctor Mariam namusoke phd
eicosanoids by doctor Mariam namusoke phd
KawukiIsah
 
c. Prostaglandins, Thromboxanes and Leukotrienes.pdf
c. Prostaglandins, Thromboxanes and Leukotrienes.pdfc. Prostaglandins, Thromboxanes and Leukotrienes.pdf
c. Prostaglandins, Thromboxanes and Leukotrienes.pdf
VISHALJADHAV100
 
PPT of Eicosanoids and PAF
PPT of Eicosanoids and PAF PPT of Eicosanoids and PAF
PPT of Eicosanoids and PAF
RamaRao Sankula
 
eicosanoids_1.ppt
eicosanoids_1.ppteicosanoids_1.ppt
eicosanoids_1.ppt
zelekeamen7
 
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,LecturerProstaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Dr. Jibachha Sah
 
Prostaglandins-Introduction and Biological Importance
Prostaglandins-Introduction and Biological ImportanceProstaglandins-Introduction and Biological Importance
Prostaglandins-Introduction and Biological Importance
PRUTHVIRAJ K
 

Similar to Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx (20)

Eicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptxEicosanoids mwisho.. For bettr understanding.pptx
Eicosanoids mwisho.. For bettr understanding.pptx
 
New style prostaglandins
New style prostaglandins New style prostaglandins
New style prostaglandins
 
Eicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical studentsEicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical students
 
Prostaglandins pharmacology
Prostaglandins pharmacologyProstaglandins pharmacology
Prostaglandins pharmacology
 
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINSSYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
SYSTEMATIC REVIEW OF THE ROLE OF PROSTAGLANDINS
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
 
Postaglandines
PostaglandinesPostaglandines
Postaglandines
 
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptxEICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
EICOSONOIDS METABOLISM FOR MBBS, LAB. MED.BDS.pptx
 
Eicosanoids
EicosanoidsEicosanoids
Eicosanoids
 
PROSTAGLANDINS
PROSTAGLANDINSPROSTAGLANDINS
PROSTAGLANDINS
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
 
Prostaglandins
ProstaglandinsProstaglandins
Prostaglandins
 
Eocosanoids
EocosanoidsEocosanoids
Eocosanoids
 
eicosanoids by doctor Mariam namusoke phd
eicosanoids by doctor Mariam namusoke phdeicosanoids by doctor Mariam namusoke phd
eicosanoids by doctor Mariam namusoke phd
 
c. Prostaglandins, Thromboxanes and Leukotrienes.pdf
c. Prostaglandins, Thromboxanes and Leukotrienes.pdfc. Prostaglandins, Thromboxanes and Leukotrienes.pdf
c. Prostaglandins, Thromboxanes and Leukotrienes.pdf
 
PPT of Eicosanoids and PAF
PPT of Eicosanoids and PAF PPT of Eicosanoids and PAF
PPT of Eicosanoids and PAF
 
eicosanoids_1.ppt
eicosanoids_1.ppteicosanoids_1.ppt
eicosanoids_1.ppt
 
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,LecturerProstaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
Prostaglandins,Angiotensin,Bradykinin-Dr.Jibachha Sah,M.V.Sc,Lecturer
 
Prostaglandins-Introduction and Biological Importance
Prostaglandins-Introduction and Biological ImportanceProstaglandins-Introduction and Biological Importance
Prostaglandins-Introduction and Biological Importance
 

More from PurushothamKN1

Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptxChemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
PurushothamKN1
 
SAR of Quinolines.pptx
SAR of Quinolines.pptxSAR of Quinolines.pptx
SAR of Quinolines.pptx
PurushothamKN1
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
PurushothamKN1
 
modify of peptidomimetics.pptx
modify of peptidomimetics.pptxmodify of peptidomimetics.pptx
modify of peptidomimetics.pptx
PurushothamKN1
 
INDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptxINDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptx
PurushothamKN1
 
.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx
PurushothamKN1
 
01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx
PurushothamKN1
 
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
PurushothamKN1
 
02.High through output screening.pptx
02.High through output screening.pptx02.High through output screening.pptx
02.High through output screening.pptx
PurushothamKN1
 
Adrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptxAdrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptx
PurushothamKN1
 
anti hypertensive agents.pptx
anti hypertensive agents.pptxanti hypertensive agents.pptx
anti hypertensive agents.pptx
PurushothamKN1
 
COX.pptx
COX.pptxCOX.pptx
COX.pptx
PurushothamKN1
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptx
PurushothamKN1
 
peptidomimetics.pptx
peptidomimetics.pptxpeptidomimetics.pptx
peptidomimetics.pptx
PurushothamKN1
 
prinz metal angina.pptx
prinz metal angina.pptxprinz metal angina.pptx
prinz metal angina.pptx
PurushothamKN1
 
prodrug.pptx
prodrug.pptxprodrug.pptx
prodrug.pptx
PurushothamKN1
 
Rationale of prodrug design.pptx
Rationale of prodrug design.pptxRationale of prodrug design.pptx
Rationale of prodrug design.pptx
PurushothamKN1
 
STEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptxSTEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptx
PurushothamKN1
 
REACTION PROGRESS KINETIC ANALYSIS.pptx
REACTION PROGRESS KINETIC ANALYSIS.pptxREACTION PROGRESS KINETIC ANALYSIS.pptx
REACTION PROGRESS KINETIC ANALYSIS.pptx
PurushothamKN1
 
REDUCTION.pptx
REDUCTION.pptxREDUCTION.pptx
REDUCTION.pptx
PurushothamKN1
 

More from PurushothamKN1 (20)

Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptxChemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx
 
SAR of Quinolines.pptx
SAR of Quinolines.pptxSAR of Quinolines.pptx
SAR of Quinolines.pptx
 
OECD GUIDELINES.pptx
OECD GUIDELINES.pptxOECD GUIDELINES.pptx
OECD GUIDELINES.pptx
 
modify of peptidomimetics.pptx
modify of peptidomimetics.pptxmodify of peptidomimetics.pptx
modify of peptidomimetics.pptx
 
INDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptxINDUSTRIAL SAFETY.pptx
INDUSTRIAL SAFETY.pptx
 
.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx.Case study and enantioselectivity in drug ADME.pptx
.Case study and enantioselectivity in drug ADME.pptx
 
01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx01. Combating Drug Resistance.pptx
01. Combating Drug Resistance.pptx
 
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
02.Anticonvulsant and H1 and H2 receptor antagonist.pptx
 
02.High through output screening.pptx
02.High through output screening.pptx02.High through output screening.pptx
02.High through output screening.pptx
 
Adrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptxAdrenergic and cholinergic agents pptx.pptx
Adrenergic and cholinergic agents pptx.pptx
 
anti hypertensive agents.pptx
anti hypertensive agents.pptxanti hypertensive agents.pptx
anti hypertensive agents.pptx
 
COX.pptx
COX.pptxCOX.pptx
COX.pptx
 
drug discovery.pptx
drug discovery.pptxdrug discovery.pptx
drug discovery.pptx
 
peptidomimetics.pptx
peptidomimetics.pptxpeptidomimetics.pptx
peptidomimetics.pptx
 
prinz metal angina.pptx
prinz metal angina.pptxprinz metal angina.pptx
prinz metal angina.pptx
 
prodrug.pptx
prodrug.pptxprodrug.pptx
prodrug.pptx
 
Rationale of prodrug design.pptx
Rationale of prodrug design.pptxRationale of prodrug design.pptx
Rationale of prodrug design.pptx
 
STEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptxSTEREOCHEMISTRY.pptx
STEREOCHEMISTRY.pptx
 
REACTION PROGRESS KINETIC ANALYSIS.pptx
REACTION PROGRESS KINETIC ANALYSIS.pptxREACTION PROGRESS KINETIC ANALYSIS.pptx
REACTION PROGRESS KINETIC ANALYSIS.pptx
 
REDUCTION.pptx
REDUCTION.pptxREDUCTION.pptx
REDUCTION.pptx
 

Recently uploaded

Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
Vivekanand Anglo Vedic Academy
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
Celine George
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
EduSkills OECD
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
Celine George
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 

Recently uploaded (20)

Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Sectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdfSectors of the Indian Economy - Class 10 Study Notes pdf
Sectors of the Indian Economy - Class 10 Study Notes pdf
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17How to Make a Field invisible in Odoo 17
How to Make a Field invisible in Odoo 17
 
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxStudents, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptx
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
How to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS ModuleHow to Split Bills in the Odoo 17 POS Module
How to Split Bills in the Odoo 17 POS Module
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 

Chemistry of Prostaglandins,Leukotrienes and Thromboxanes.pptx

  • 1. CHEMISTRY OF PROSTAGLANDINS, LEUKOTRIENES AND THROMBOXANES Presenting by, Mr Purushotham KN Sir Asst.Professor Department of Pharm.Chemistry. SACCP,B.G.Nagara 2021-2022
  • 2. CONTENTS :- Eicosanoids 1. Prostaglandins  Introduction  Classification  Chemical structure  Biosynthesis of Prostaglandin  Regulation of Prostaglandin  Mechanism of action  Theraupeutic uses 2. Leukotrienes  Introduction  Biosynthesis of Leukotrienes  Mechanism of action  Function of Leukotrienes 3. Thromboxanes  Introduction  Biosynthesis of Thromboxanes  Function of Thromboxanes  Application
  • 3. Eicosanoids INTRODUCTION Eicosanoids are oxidised derivatives of 20-carbon polyunsaturated fatty acids (PUFAs) formed by the cyclooxygenase (COX), lipoxygenase (LOX) and cytochrome . Eicosanoids are Classified as 1. Prostanoids • Prostaglandins • Prostacyclins • Thromboxanes 2. Leukotrienes • Leukotrienes A4 • Leukotrienes B4 • Leukotrienes C4 • LeukotrienesD4 • Leukotrienes E4
  • 4. 3. Lipoxins • Lipoxins A4 • Lipoxins B4 All Eicosanoids contain 20 carbon atom Eicosanoids are considred as Locally acting hormone with wide range of biochemical Function And also Arachidonic acid is Precursor of eicosanoids in human beings.
  • 6.  The prostaglandins (PG) are a group of physiologically active lipid compounds called eicosanoids having diverse hormone-like effects in animals. Prostaglandins have been found in almost every tissue in humans and other animals. They are derived enzymatically from the fatty acid that is arachidonic acid  Prostaglandin are derivative from hypothetical 20 carbon fatty acid which is called as prostanoic acid and hence the name is prostanoid.
  • 7. The prostanoid has a 5 carbon cyclopentane ring which is form by carbon 8 to carbon 12 and it has 2 side chain 1 chain of 7 carbons these lied above plane of ring and other chain has below the ring. Each of the biological active prostaglandin it has a hydroxyl group at carbon number 15.
  • 8. Classification of Prostaglandins  There is 9 classes of Prostaglandins that are  Prostaglandin A, Prostaglandin B, Prostaglandin C, Prostaglandin D, Prostaglandin E, Prostaglandin F, Prostaglandin G, Prostaglandin H, Prostaglandin I  Prostaglandin are classified into three series.  1 series which consist 1 double bond from linoleic acid Prostaglandin E1.  2 series which consist 2 double bond from Arachidonic acid Prostaglandin E2.  3 series which consist 3 double bond from Eicosapentaenoic acid Prostaglandin E3.
  • 9. OH CH3 O O H O OH Prostaglandin E2  And double bond between carbon 13 and 14 various substituent at the cyclopentane ring.  And also these structure has keto group at carbon 9 and hydroxyl group at carbon 11. Chemical structures
  • 10. OH CH3 O H O OH O H Prostaglandin F2 These is the structure of Prostaglandine F2. It has hydroxyl group at carbon number 9 and 11. As other biologically active prostaglandin it has hydroxyl group at carbon number 15. double bond between 13 and 14.
  • 11. Chemical structure of prostacyclins Prostacyclins contain additional ring formed by cyclization of side chain by linkage of carbon 6 to carbon 9 through oxygen atom on that why it is called as Prostacyclins.
  • 13. Thromboxane had derivatives of oxane ring and it is a six memebered ring intrepted by oxygen atom. these is interupted by oxygen ring and also they are synthesized from arachidonic acid. And also it synthesize in human body and it has additional oxygen atom joined with carbon 9 and 11. Prostaglandin are derivative of prostanoic acid which is 20 carbon fatty acid and they are most potent biologically substances. It produced in almost tissue except erythrocytes. Thromboxane
  • 14. Prostaglandin are different from true hormone in human body Prostaglandins are thought to be local hormone secrete by prostate hormone. And also prostaglandin were first isolated from prostate gland secreation hence it named as prostaglandin.
  • 15. Sweedish scientist Ulf van euler got nobel prize in 1970 for discovery of prostaglandin. Prostaglandin actually derived from fatty acid called as Arachidonic acid which is 20 Carbon fatty acid.
  • 16. Biosynthesis of Prostaglandin  At cellular level where are the prostaglandins produced and also prostaglandin are very unstable compound and there half life around 30 seconds.  Prostaglandin synthesis is take place from the membrane phospholipids.  From the memebrane phospholipid it is cleaved by phospholipid A2 It release precurser for prostaglandin synthesis which is arachidonic acid.  From that arachidonic acid in sequential enzymatic step prostaglandin would be produced.
  • 17.  This crucial step whenever it is required synthesize phospholipid A2 releases arachidonic acid from membrane phospholipid there by prostaglandin synthesis takes place.  Now key enzyme for prostaglandin synthesis pathway is Prostaglandin H synthase.  Prostaglandin H synthase has 2 kind of activity one cyclooxygenase activity and peroxidase activity.  Cyclooxygenase activity forms prostaglandin G2 from arachidonic acid.  And also peroxidase activity that reduces prostaglandin G2 to prostaglandin H2.
  • 18.
  • 19.
  • 20. Regulation of Prostaglandin production  The prostaglandin the key raw material of prostaglandin production is arachidonic acid derived from cell membrane.  And it is triggered by a enzyme which is phospholipase A2.  Now modulating phospholipase A2 activity the prostaglandin production from arachidonic acid derived from cell membrane.  And it is triggered by a enzyme which is phospholipase A2 activity the prostaglandin production can be regulated.  It turns out epinephrine Thrombin, Angiotensin ll , Bradykinin, vasopressin are positively regulate phospholiphase A2 and that leads to production of prostaglandin.
  • 21.  Steroid kind of inhibit prostaglandin A2 activity and there by prevent production of prostaglandin.  Prostaglandin H synthase its activity triggered by cathecolamines.  Where as it inhibit by compound like methyl salysilate and similar compound like aspirin and others.
  • 22.
  • 23. Mechanism of Action  Prostaglandin found to be working G protein couple receptor signalling pathway.  An often prostaglandin stimulation leads to increase in cyclic Amp and protein kinase.  A activation followed by several nuclear changes in terms of chin expression.  Several Prostaglandin has several effect on different level example prostaglandin I2 leads to vascular dilation.
  • 24.  Whereas thromboxanes which is secreated or prevently present in thrombocyte they induce vasoconstriction.  And also these two has opposite function.  Now prostaglandin I2 which is known as prostacyclin prevent platelet aggregation.  Where as thromboxanes promote platelet aggregation.  In which prostaglandin F2 are stimulates uterine muscle contraction sometimes used to terminate pregnancy.  Now Prostaglandin E and Prostaglandin F has opposing role in terms of broncho constriction and broncho dilation.
  • 25.  Prostaglandin F leads bronchial smooth muscle constriction where PGE leads to dilation of the bronchials.  Prostaglandin E2 and Prostaglandin D2 increase capillary permeability enabling neutrophill and other imune cell to be extravated from particular blood capillary near by the tissue and it also implicate in terms of inflamation. So that Prostaglandin E2 and prostaglandin D2 are involved in inflammatory responses. Now overall prostaglandin prevent are decrease gastric secreation and increase intestinal mobility.
  • 26. THERAUPEUTIC USES Abortion : PGs have a place in midterm abortion, missed abortion. Methotrexate alongwith misoprostol is also highly successful for inducing abortion in the first few weeks of pregnancy. Pretreatment with mifepristone improves the efficacy of PGE2 as abortifacient. Cervical priming : Applied Intravaginally or in the cervical canal, low doses of PGE2 which do not affect uterine motility, make the cervix soft and compliant.
  • 27. Glaucoma : Topical PGF2a analogues like lanatoprost, bimatoprost that are receptor agonists are the first choice drugs in wide angle glaucoma. Peptic ulcer : PGEI (misoprostol) is occasionally used for healing peptic ulcer. Avoid Platelet damage : PGI2 (Epoprostenol) can be used to prevent platelet aggregation and damage during haemodialysis.
  • 28. Leukotrienes INTRODUCTION  Leukotrienes is kind of similar leukocytes. It kind of associated with Leukocytes.  Trienes are tell us some features of chemical.  There are 3 consecutive double bond.  Now we understand leukotrienes as kind of chemical molecules which might have chemical features 3 consecutive double bond found in leukocytes.  So these leukotrienes are actually a family of eicosanoids (arachidonic acid derivatives).
  • 29.  Leukotrienes are inflammatory mediators just like other arachidonic derivative such as prostaglandin.  Leukotrienes are a family of eicosanoid inflammatory mediators produced in leukocytes by the oxidation of arachidonic acid (AA) and the essential fatty acid eicosapentaenoic acid (EPA) by the enzyme arachidonate 5-lipoxygenase.  Leukotrienes use lipid signaling to convey information to either the cell producing them (autocrine signaling) or neighboring cells (paracrine signaling) in order to regulate immune responses.  The production of leukotrienes is usually accompanied by the production of histamine and prostaglandins, which also act as inflammatory mediators.
  • 30.
  • 31. 5-lip-oxygenase act on arachidonic acid to form 5- hydroperoxyeicosatetraenoic acid . Acts and associate with 5-lox activating protein. The 5HPETE later converted into leukotriene A4 also it is unstable and rapidly hydrolyse by the action of enzyme by leukotriene A4 hydrolase to form leukotriene B4 in neutrophils and monocytes. The LTB4 is one of the most potent inflammation mediating lipids. And LTA4 (Leukotriene A4) which forms leukotriene C4 which incorporate with glutathion and with action of LTC4 synthase it forms leukotrienes C4. Biosynthesis of Leukotrienes
  • 32. This forms in mast cells and eosinophills. Later Leukotriene C4 release glutamate to forms leukotriene D4. Later leukotriene D4 release glycine it forms leukotriene E4.
  • 33.
  • 34.
  • 35. MECHANISM OF ACTION  Which is usually accompanied with the production of prostaglandins and histamines which are inflamattory mediators from arachidonic acid there could be production of leukotrienes and also in otherside which form prostaglandin derivatives which also take part in inflammatory response.  Leukotrienes receptors are class of G-Protein couple receptor so generally work by elevation of cyclic Amp in the cell and leads to several inflammatory cytokinin genes.  But few leukotrienes receptor also nuclear receptor type.
  • 36.  And these receptor generally found in easinophil, endothelial cells, mast cells.  In endothelial cells and also found in smooth muscles cells important role in smooth muscle contraction and they form physiological role incase of disease.
  • 37. Function of Leukotrienes Major role of leukotrienes (specially, leukotrienes D4) is to trigger contraction in the smooth muscle lining the bronchioles. Contraction of branchioles is triggered by leukotriene and these is the key underline feature rhinitis or asthma like diseases. Leukotrienes contribute to the pathophysiology of asthma, especially in patients with aspirin. Exacerbated respiratory disease whose symptoms are Airflow obstruction, Increased secretion of mucus, Mucosal accumulation, Broncho constriction, Infiltration of inflammatory cells in the airway wall.
  • 38. Excess of leukotriene leads to anaphylactic shock.
  • 39. Excess of leukotriene leads to anaphylactic shock And also leukotrienes inhibitors could be useful for patients with later stages of alzheimer disease. And also improve memory loss And also Leukotrienes classified as Leukotrienes A4 Leukotrienes B4 Leukotrienes C4 Leukotrienes D4 Leukotrienes E4 Leukotrienes designated as 4 because 4 double bond in their structures are
  • 40. Leukotrienes are involved in the inflammation and immediate hypersensitivity reaction. Leukotriene B4  Increased chemotaxis of polymorphonuclear leukocytes.  Chemotaxis are directed migration of cell in response to chemical stimulus such as growth factor.  Release of lysosomal enzymes, adesion of white blood cells.
  • 41. Leukotriene C4 , Leukotriene D4, Leukotriene E4 • Involved in contraction of smooth muscle. • They cause Bronchoconstriction, and Vasoconstriction. • They also called as slow reacting substance of anaphylaxis. • Anaphylaxis is seveir potentially life threatening allergic reaction. • And this reaction occur within seconds or minutes of exposure to allergens.
  • 42. Thromboxanes INTRODUCTION  Thromboxane is named for its role in clot formation.  Thromboxane is a member of the family of lipids known as eicosanoids and also it is derived from arachidonic acid.  Arachidonic acid get converted into thromboxane A2 and thromboxane B2.  Key enzyme help in these process is known as thromboxane-A-synthase.  Both thromboxanes are characterized as 6-membered ether containing cyclic ring.
  • 43.
  • 44. Biosynthesis of Thromboxanes o Thromboxanes is synthesized in platelet. o On the platelet membrane they would be phospholiphase and these would generate arachidonic acid. o The arachidonic acid converted initially prostaglandin H2 with the help of cyclo oxygenase. o Later prostaglandin H2 is converted into either prostacyclin with the help of prostacyclin synthase or it can converted into thromboxane A2 with the help of Thromboxane A synthase. o These Thromboxane A Synthase enzyme exclusively present in the platelet membrane. Platelet is the site of thromboxane production.
  • 45. Thromboxane once generated can bind to thromboxane receptor present in wide variety of cell for example blood vessel. Thromboxane ultimately leads to G-protein mediating signalling which elevates calcium level in cytoplasm. Once calcium level elevated it helps in clot formation or eventually in vasoconstriction.
  • 46.
  • 47. Function of Thromboxanes  One of the major function of the thromboxane is to perform vasoconstriction.  Thromboxane and prostacyclin has opposite role.  Prostacyclin has vasodilatory role where as thromboxanes has vasoconstriction role.  And also vasoconstriction caused by thromboxanes play a role in prinz metal ’s angina and blocked coronary artery.  Any kind of cardiac inflammatory disease one of the leading role could be played by thromboxanes.  In immune diet if human body has sufficient omega 3 fatty acid thromboxane A3 has generated instead of thromboxane A2.
  • 48.  While thromboxane A2 is potent vasoconstrictor and thromboxane A3 is less potent vasoconstrictor.  Vasoconstriction mediated effect is less if diet contain omega 3 fatty acid  In this synthesis of thromboxane by blocking cycloxygenase specific substance such has aspirin can block production of thromboxane.  Other than thromboxane synthase inhibitor inhibit thromboxane A-synthase.
  • 49. APPLICATION OF THROMBOXANES  Thromboxanes exert hormone-like Application.  They interact with G-protein-linked receptors on the cell surface to activate signal transduction pathways inside the cell.  TXs modify inflammatory responses but are most well-known for their role in platelet aggregation, vasoconstriction, and smooth muscle proliferation – they are an essential part of the wound repair mechanism.  Thromboxane synthesis and thus platelet aggregation is inhibited by non-steroidal anti-inflammatory drugs like aspirin.
  • 50.
  • 51. References  https://pubmed.ncbi.nlm.nih.gov/32808658/#:~:text=Eicosanoids%20 are%20oxidised%20derivatives%20of,usual%20substrate%20for%20 eicosanoid%20synthesis.  Medical pharmacology by KD Tripathi, 8th edition Page no-197 to 208.  Medicinal chemistry by Prof. Surendra Nath Pandeya Page no- 239 to 249.  https://en.m.wikipedia.org/wiki/Thromboxane#:~:text=Thromboxane %20is%20a%20vasoconstrictor%20and,from%20platelets%20is%20s till%20unclear.  https://en.m.wikipedia.org/wiki/Prostaglandin  https://en.m.wikipedia.org/wiki/Leukotriene  Medicinal chemistry by K.Ilango & P valentina Page no-968-999.